TQ development support

Ended Definitive Contract Awarded Last action

Contract number
W81XWH16C0002
Awardee
Awarding agency
Obligated
$9,039,154

Award facts

Opportunity
  • W81XWH15R0039 Solicitation number
Contract value 95% obligated
  • $9,039,380.80 Current, with exercised options
  • $9,514,715.80 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 2 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
North Potomac, MD, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00016 · Tafenoquine development support -$227
Other Administrative Action P00015 · TQ development support for usammda $0
Supplemental Agreement for work within scope P00014 · Tafenoquine development support $113,907
Funding Only Action P00013 · The purpose of this MOD is to send the final incremental funding for clin 0001. This effort will enable the tafenoquine drug development program to continue the… $290,811
Funding Only Action P00012 $400,000
Funding Only Action P00011 · Incremental funding supporting the advancement of tafenoquine (TQ) product contract for the u. S. Army medical research and materiel command (usamrmc) $830,145
Funding Only Action P00010 · Modification for incremental funding, TQ development support $750,000
Funding Only Action P00009 $600,000
Additional Work (new agreement, FAR part 6 applies) P00008 $0
Funding Only Action P00007 · TQ development support, decrement clin 0002, increment clin 0001 $0
Supplemental Agreement for work within scope P00006 $713,910
Supplemental Agreement for work within scope P00005 $0
Funding Only Action P00004 $1,486,224
Exercise an Option P00003 $707,804
Supplemental Agreement for work within scope P00002 -$707,804
Other Administrative Action P00001 $0
Original award $3,854,384
Show all 17

About this award

Written by GovTribe AI ·

This is a $9,514,715.80 cost-plus-fixed-fee contract awarded by the U.S. Army Medical Command (MEDCOM) to Fast-Track Drugs & Biologics, L.L.C., a woman-owned small business. The contract, titled "TQ DEVELOPMENT SUPPORT", was awarded on November 23, 2015, with a final completion date of September 25, 2020. The contract supports research and development activities, including clinical trial management and data analysis, focused on pharmaceutical treatments for alcohol use disorder. Fast-Track Drugs & Biologics has extensive experience working with the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health (NIH), on similar research efforts. The contract has a total small business set-aside designation.

Quick answers

Who was awarded contract W81XWH16C0002?

W81XWH16C0002 was awarded to Fast-Track Drugs & Biologics, L.L.C. by Medical Command (Department of the Army) on November 23, 2015.

How much is contract W81XWH16C0002 worth?

The government has obligated $9,039,154 on W81XWH16C0002. Its current value, with exercised options, is $9,039,381. Its potential value, with all options, is $9,514,716.

Was contract W81XWH16C0002 competed?

The extent of competition for W81XWH16C0002 was full and open competition after exclusion of sources. The government received 2 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login